These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 16935891

  • 1. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

  • 2. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 3. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J.
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [Abstract] [Full Text] [Related]

  • 4. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 6. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 7. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L, Lei MX, Chen HL, Wu J, Guo LJ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
    [Abstract] [Full Text] [Related]

  • 8. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T.
    Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H.
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [Abstract] [Full Text] [Related]

  • 10. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 11. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Dec 20; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 12. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowska M, Siewko K, Nikołajuk A, Kinalska I, Górska M.
    Diabetes Metab Res Rev; 2008 Dec 20; 24(4):310-7. PubMed ID: 18273859
    [Abstract] [Full Text] [Related]

  • 13. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Dec 20; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 14. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus.
    Okonogi H, Nishimura M, Utsunomiya Y, Hamaguchi K, Tsuchida H, Miura Y, Suzuki S, Kawamura T, Hosoya T, Yamada K.
    Clin Nephrol; 2001 May 20; 55(5):357-64. PubMed ID: 11393380
    [Abstract] [Full Text] [Related]

  • 15. [Determination of serum highly sensitive C-reactive protein in patients with type 2 diabetes].
    Li CZ, Xue YM, Gao F, Wang M.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul 20; 24(7):791-3. PubMed ID: 15257905
    [Abstract] [Full Text] [Related]

  • 16. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul 20; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 17. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P, Chan SP.
    Malays J Pathol; 2010 Jun 20; 32(1):43-7. PubMed ID: 20614725
    [Abstract] [Full Text] [Related]

  • 18. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW, Yao QH, Weng QF, Su BL, Zhang X, Xiong JH.
    J Pharm Biomed Anal; 2004 Sep 21; 36(1):101-4. PubMed ID: 15351053
    [Abstract] [Full Text] [Related]

  • 19. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun 21; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH.
    Diabet Med; 2005 Jan 21; 22(1):14-20. PubMed ID: 15606685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.